These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3140215)

  • 1. Quality control in intravenous additive service.
    Vermeij P
    Pharm Weekbl Sci; 1988 Aug; 10(4):151-3. PubMed ID: 3140215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical guides. I: Central intravenous additive services.
    Allwood MC
    J Clin Pharm Ther; 1994 Jun; 19(3):137-45. PubMed ID: 7962218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive pharmacy services in an 85-bed hospital.
    Tanner DJ
    Am J Hosp Pharm; 1976 Apr; 33(4):340-9. PubMed ID: 817598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality assurance in the provision of hospital care. Medication process: who's responsible?
    Beste DF; de Leon RF
    Hospitals; 1974 Mar; 48(5):97-100. PubMed ID: 4815748
    [No Abstract]   [Full Text] [Related]  

  • 5. Practical approaches to quality assurance of clinical pharmacy programs: a review.
    Rodriguez LR; Weber C
    Top Hosp Pharm Manage; 1988 Feb; 7(4):24-34. PubMed ID: 10314264
    [No Abstract]   [Full Text] [Related]  

  • 6. Recommended guidelines for quality assurance in hospital centralized intravenous admixture services. National Coordinating Committee on Large Volume Parenterals.
    Am J Hosp Pharm; 1980 May; 37(5):645-55. PubMed ID: 7386471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality control in admixture services.
    Zellmer WA
    Am J Hosp Pharm; 1978 May; 35(5):527-8. PubMed ID: 655175
    [No Abstract]   [Full Text] [Related]  

  • 8. Personnel costs and preparation time in a centralized intravenous admixture program.
    Ryan DM; Daniels CE; Somani SM
    Am J Hosp Pharm; 1986 May; 43(5):1222-5. PubMed ID: 3087164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assuring safe use of parenteral dosage forms in hospitals.
    Cohen MR; Davis NM
    Hosp Pharm; 1990 Oct; 25(10):913-5. PubMed ID: 10107392
    [No Abstract]   [Full Text] [Related]  

  • 10. Reducing i.v. waste to under 2.25 percent.
    Newhouse JG; Paul VM; Waugh NA; Frye CB
    Hosp Pharm; 1988 Mar; 23(3):241-2, 246-7. PubMed ID: 10312459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality assurance audit of an intravenous drug delivery system.
    Hagel HP; Lenze CJ; Olson PA
    Am J Hosp Pharm; 1988 Jun; 45(6):1359-60. PubMed ID: 3414707
    [No Abstract]   [Full Text] [Related]  

  • 12. Review of the justification for pharmacy parenteral admixture preparation.
    Schneider PJ
    Hosp Pharm; 1981 Sep; 16(9):476, 478-9, 484. PubMed ID: 10252377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommended methods for compounding intravenous admixtures in hospitals.
    Am J Hosp Pharm; 1975 Mar; 32(3):261-70. PubMed ID: 1136973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASHP therapeutic position statement on the institutional use of 0.9% sodium chloride injection to maintain patency of peripheral indwelling intermittent infusion devices.
    Benner K; Lucas AJ
    Am J Health Syst Pharm; 2012 Jul; 69(14):1252-4. PubMed ID: 22761082
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of i.v. push guidelines.
    Sullivan V; Koch KE
    Am J Hosp Pharm; 1992 Oct; 49(10):2427, 2433. PubMed ID: 1442814
    [No Abstract]   [Full Text] [Related]  

  • 16. Expiry date guidelines for a centralized IV admixture service.
    Stroup JW; Mighton-Eryou LM
    Can J Hosp Pharm; 1986 Jun; 39(3):57-9, 66. PubMed ID: 10311616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Economic assessment of different administration modes for total parenteral nutrition].
    Achach K; Peroux E; Hébuterne X
    Gastroenterol Clin Biol; 2002; 26(8-9):680-5. PubMed ID: 12434068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Word-processing system in a centralized intravenous admixture program.
    Kirschenbaum BE
    Am J Hosp Pharm; 1982 Oct; 39(10):1690-2. PubMed ID: 6816065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of oral communication on intravenous wastage: talk is cheap.
    Boomer G; Savoy LB; Marten R
    Hosp Pharm; 1993 May; 28(5):404-5, 407-9. PubMed ID: 10126024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Centralized intravenous additive services (CIVAS): the state of the art in 2010.
    Hecq JD
    Ann Pharm Fr; 2011 Jan; 69(1):30-7. PubMed ID: 21296215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.